nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
74 Adherence to rhDNase inhaled via an AKITA2® APIXNEB device during a clinical trial
|
Kroneberg, P. |
|
2011 |
10 |
Supplement 1 |
p. S19- 1 p. |
artikel |
2 |
315* Cardiac autonomic neuropathy (CAN) is more likely to occur in cystic fibrosis (CF) patients with or without diabetes than in patients with type 1 diabetes (T1DM)
|
Rashid, R. |
|
2011 |
10 |
Supplement 1 |
p. S80- 1 p. |
artikel |
3 |
Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis
|
Dalbøge, C.S. |
|
2011 |
10 |
Supplement 1 |
p. 318-325 8 p. |
artikel |
4 |
Colon cancer in lung transplant recipients with CF: Increased risk and results of screening
|
Meyer, Keith C. |
|
2011 |
10 |
Supplement 1 |
p. 366-369 4 p. |
artikel |
5 |
108 Comparative in vitro characterisation of colistimethate sodium 1 MIU/3 ml versus 2 MIU/4 ml in an eFlow® rapid Nebuliser
|
Bucholski, A. |
|
2011 |
10 |
Supplement 1 |
p. S28- 1 p. |
artikel |
6 |
1* Comparison of bioinformatics, reporter minigene and mRNA study to analyse the effect of unclassified variants on CFTR mRNA splicing
|
Audrézet, M.-P. |
|
2011 |
10 |
Supplement 1 |
p. S1- 1 p. |
artikel |
7 |
252* Correlation of physical performance and quality of life in adult patients with cystic fibrosis
|
Hofer, M. |
|
2011 |
10 |
Supplement 1 |
p. S64- 1 p. |
artikel |
8 |
Cystic fibrosis in Chilean patients: Analysis of 36 common CFTR gene mutations
|
Lay-Son, Guillermo |
|
2011 |
10 |
Supplement 1 |
p. 66-70 5 p. |
artikel |
9 |
388 Detection of a novel CFTR mutation c.122C>G (p.Pro41Arg) in a young cystic fibrosis (CF) patient with recurrent respiratory symptoms
|
De Wachter, E. |
|
2011 |
10 |
Supplement 1 |
p. S100- 1 p. |
artikel |
10 |
Effect of an antioxidant-rich multivitamin supplement in cystic fibrosis
|
Sagel, Scott D. |
|
2011 |
10 |
Supplement 1 |
p. 31-36 6 p. |
artikel |
11 |
116 Effect of nebulised antibiotics on Aspergillus colonisation and complications
|
Lumb, C. |
|
2011 |
10 |
Supplement 1 |
p. S30- 1 p. |
artikel |
12 |
329* Effects of clinical variables and social status on clinic defaulting in adult CF (cystic fibrosis) patients
|
Ashish, A. |
|
2011 |
10 |
Supplement 1 |
p. S84- 1 p. |
artikel |
13 |
206 Eosinopenia and severity of pulmonary exacerbations in adult cystic fibrosis patients
|
Williams, K. |
|
2011 |
10 |
Supplement 1 |
p. S52- 1 p. |
artikel |
14 |
165 Evaluation of antibody against Pseudomonas aeruginosa in intermittently infected cystic fibrosis patients
|
Dolce, D. |
|
2011 |
10 |
Supplement 1 |
p. S42- 1 p. |
artikel |
15 |
375 Expression of cystic fibrosis (CF) at diagnosis in a reference center in Rio de Janeiro
|
Schwan, P.J. |
|
2011 |
10 |
Supplement 1 |
p. S96- 1 p. |
artikel |
16 |
294 High requirement of pancreatic enzyme dose
|
Araujo, M. |
|
2011 |
10 |
Supplement 1 |
p. S75- 1 p. |
artikel |
17 |
162* Identical obligate anaerobic bacteria in periodontal pockets and sputum of cystic fibrosis patients
|
Huse, A. |
|
2011 |
10 |
Supplement 1 |
p. S41- 1 p. |
artikel |
18 |
Impact of polymorphism of Multidrug Resistance-associated Protein 1 (ABCC1) gene on the severity of cystic fibrosis
|
Mafficini, Andrea |
|
2011 |
10 |
Supplement 1 |
p. 228-233 6 p. |
artikel |
19 |
Impact of the A (H1N1) pandemic influenza (season 2009–2010) on patients with cystic fibrosis
|
Viviani, Laura |
|
2011 |
10 |
Supplement 1 |
p. 370-376 7 p. |
artikel |
20 |
Impaired expression of hypoxia-inducible factor-1α in cystic fibrosis airway epithelial cells – A role for HIF-1 in the pathophysiology of CF?
|
Legendre, Claire |
|
2011 |
10 |
Supplement 1 |
p. 286-290 5 p. |
artikel |
21 |
Measuring health-related quality of life in clinical trials in cystic fibrosis
|
Abbott, J. |
|
2011 |
10 |
Supplement 1 |
p. S82-S85 4 p. |
artikel |
22 |
Multicentre trial of weekly risedronate on bone density in adults with cystic fibrosis
|
Haworth, Charles S. |
|
2011 |
10 |
Supplement 1 |
p. 470-476 7 p. |
artikel |
23 |
270* Neuroendocrine characterization of the intestine of F508del CFTR mice
|
Hielte, L. |
|
2011 |
10 |
Supplement 1 |
p. S69- 1 p. |
artikel |
24 |
312* New onset diabetes after lung transplantation in patients with cystic fibrosis compared with patients suffering from other lung diseases
|
van Meerkerk, G. |
|
2011 |
10 |
Supplement 1 |
p. S79- 1 p. |
artikel |
25 |
238 Paediatric physiotherapy review following the introduction of newborn screening in cystic fibrosis
|
Byrne, N.M. |
|
2011 |
10 |
Supplement 1 |
p. S60- 1 p. |
artikel |
26 |
344 Patient education: a pedagogic tool for cystic fibrosis transmission and fertility: GENOUTIL
|
David, V |
|
2011 |
10 |
Supplement 1 |
p. S88- 1 p. |
artikel |
27 |
130 Prevalence of TSST-1-, PVL- and SEA-producing Staphylococcus aureus in cystic fibrosis patients
|
Filleron, A. |
|
2011 |
10 |
Supplement 1 |
p. S33- 1 p. |
artikel |
28 |
220 Respiratory and nutritional effects of long-term treatment with azithromycin in patients with cystic fibrosis
|
Fustik, S. |
|
2011 |
10 |
Supplement 1 |
p. S56- 1 p. |
artikel |
29 |
378 Saliva sodium and chloride levels: a useful tool for cystic fibrosis (CF) diagnosis?
|
Gonçalves, A.C. |
|
2011 |
10 |
Supplement 1 |
p. S97- 1 p. |
artikel |
30 |
56 The calpain-calpastatin system in cystic fibrosis: physiopathological implications
|
Averna, M. |
|
2011 |
10 |
Supplement 1 |
p. S14- 1 p. |
artikel |
31 |
71 The effect of N-acetylcysteine on the visco-elasticity of sputum of cystic fibrosis patients
|
van Daele, S.G. |
|
2011 |
10 |
Supplement 1 |
p. S18- 1 p. |
artikel |
32 |
361 The influence of experiential avoidance on depression, anxiety and life quality in adult cystic fibrosis (CF) patients
|
Schusser, S. |
|
2011 |
10 |
Supplement 1 |
p. S92- 1 p. |
artikel |
33 |
148 The influence of moulds as an independent risk factor for decreasing lung function in cystic fibrosis
|
Guy, C.E. |
|
2011 |
10 |
Supplement 1 |
p. S37- 1 p. |
artikel |
34 |
298 Vitamin deficiency in children with cystic fibrosis
|
Olesen, A.M. |
|
2011 |
10 |
Supplement 1 |
p. S75- 1 p. |
artikel |
35 |
41* Who should be analyzed in a cystic fibrosis registry?
|
Thomas, M. |
|
2011 |
10 |
Supplement 1 |
p. S10- 1 p. |
artikel |